ArticleFrontiers in oncology2026

Immune-related adverse events and clinical outcomes in patients with solid tumors treated with adebrelimab: a real-world exploratory study.

Yifan Chao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.